Skip to main content
OpenTrials

Clinical trial condition

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Explore clinical trials studying Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Study availability and eligibility vary by location and protocol.

8 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial results

Recruiting

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT07526493

Conditions
Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +37 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04281472

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Investigator site 0010065 Birmingham, Alabama, United States
  • Investigator site 0010013 Phoenix, Arizona, United States
  • Investigator site 0010055 Scottsdale, Arizona, United States
  • Investigator Site 0010032 Carlsbad, California, United States
View all 216 locations
View Trial Details
Completed

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT02027701

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Site Reference 8400181 Birmingham, Alabama, United States
  • Site Reference 8400167 Los Angeles, California, United States
  • Site Reference 8400166 Kansas City, Kansas, United States
  • Site Reference 8400169 New York, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04280718

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Investigator site 0010065 Birmingham, Alabama, United States
  • Investigator site 0010013 Phoenix, Arizona, United States
  • Investigator site 0010055 Scottsdale, Arizona, United States
  • Investigator site 0010032 Carlsbad, California, United States
View all 147 locations
View Trial Details

Related conditions